Jump to navigation

Draft pandemic treaty could force Big Pharma to share vaccines with developing countries

Major battles lie ahead as negotiations on a new treaty to set rules for production and distribution of life-saving drugs

Negotiations on protocols for a global and national level pandemic response have started with the World Health Organization's (WHO) Intergovernmental Negotiating Body's (INB) publication of a 'zero-draft' of a new pandemic treaty last week.

The draft states that the WHO is 'deeply concerned by the gross inequities' of supply, production and access to Covid-19 vaccines. Its proposal to reserve at least 20% of any tests, vaccines or treatments for use in poorer countries is likely to prompt major pushback from pharmaceutical giants.

Civil society groups say the treaty should compel governments to commit to sharing medical technology and knowhow. It also states that the intellectual property rules that uphold pharmaceutical company monopolies must be waived automatically when a health emergency is declared.

This points to the need for clear enforcement of the treaty which raises another raft of diplomatic questions. The WHO insists the treaty should be legally binding.

The draft cites the backdrop to its recommendations as the 'catastrophic failure of the international community in showing solidarity and equity in response to the novel Covid-19 pandemic'. The final draft is set to be presented at the World Health Assembly in 2024.

Other proposals in the draft include strengthening and sustaining capacities of health systems, cooperation for sustainable and predictable financing, and raising pandemic and public health literacy for pandemic prevention, preparedness, response and recovery.

It also calls for the establishment of the WHO Global Pandemic Supply Chain and Logistics Network to promote production and transfer of technology and know-how.

This network would boost research and development capacities and establish a Pathogen Access Benefit-Sharing System (PABS) to ensure equitable and timely sharing of pathogens with pandemic potential and genomic sequences.



Related Articles

The war for the cure

International rivalries and empire-building are shaping the response to the pandemic in Africa

Serial financial crises and political meddling have weakened the operations of the World Health Organisation for decades but the rivalries between the United States and China over the...

READ FOR FREE

Kudos to the health-workers

Despite grandstanding by some senior politicians, it is the doctors and nurses who are winning public support in the fight against the coronavirus

Criticisms are mounting about the lack of a coherent national strategy to manage the coronavirus pandemic. The missing piece is effective leadership from the national task force, under...


Pandemic prospects

Cases are increasing rapidly but lockdown policies have been easing and there is little public or political appetite to tighten them again

With Covid-19 positive cases doubling in the last two weeks, Africa is expected to notch up its millionth patient in the coming days. 'We are at a pivotal...


Nkengasong sings

The African Union's decision to grant autonomy to the African Centres for Disease Control and Prevention marks a victory for its highly regarded director John Nkengasong, who had...


A scramble for vaccines

Despite pious pledges of equal access to the shots, Africa is losing out. Fixing that will take more cooperation and bold policy

While the outgoing chair of the African Union, South Africa's President Cyril Ramaphosa, was able to make a triumphant announcement on 13 January that the AU had 'secured'...